Trevi Therapeutics Inc (NASDAQ:TRVI)’s traded shares stood at 1.1 million during the last session, with the company’s beta value hitting 0.97.The TRVI share’s 52-week high
In last trading session, Trevi Therapeutics Inc (NASDAQ:TRVI) saw 0.6 million shares changing hands with its beta currently measuring 0.98. Company’s recent per share price
During the last session, Trevi Therapeutics Inc (NASDAQ:TRVI)’s traded shares were 0.37 million, with the beta value of the company hitting 1.01. At the end
In the latest trading session, 0.57 million Trevi Therapeutics Inc (NASDAQ:TRVI) shares changed hands as the company’s beta touched 0.99. With the company’s most recent
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
